Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
recent articles
Courtesy of Dr. Pulin S Kothari, MD, MD from Katy, TX. A stomach biopsy with an interesting...
About Aperio Aperio is the market leader in digital pathology, which is a digital environment for the management and interpretation of pathology information that originates with a digital slide. April Science...
Nice case with multiple fields and images at epathologies.com. Make sure to check out the pdf presentation as...
If you haven't seen this yet - Aperio blog has story on "Interpath - Pathology on the iPhone" Interpath for iPhone from IMI on...
Attending the HIMSS meeting next week. This press release about Mayo and IBM was released in advance of the meeting but I gather we will all be hearing more about similar technlogies and initiatives as the meeting progresses through next...
From Medical News Today. Time will tell if this is a useful marker in the clinical setting in prostate cancer. What I find most interesting about the press release is the statement about expected "launch of a series of...
